UBS Group’s FT Vest US Equity Enhance & Moderate Buffer ETF March XMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-842
Closed -$33.6K 11254
2025
Q4
$33.6K Buy
842
+230
+38% +$9.09K ﹤0.01% 7456
2025
Q3
$24K Sell
612
-1,903
-76% -$73.8K ﹤0.01% 8038
2025
Q2
$96.3K Sell
2,515
-1,074
-30% -$39.7K ﹤0.01% 7270
2025
Q1
$132K Buy
3,589
+3,197
+816% +$117K ﹤0.01% 6829
2024
Q4
$14.2K Sell
392
-11,574
-97% -$415K ﹤0.01% 8105
2024
Q3
$425K Buy
11,966
+11,388
+1,970% +$397K ﹤0.01% 5343
2024
Q2
$20K Buy
+578
New +$19.6K ﹤0.01% 7305
2024
Q1
Sell
-4,720
Closed -$155K 10111
2023
Q4
$155K Buy
4,720
+4,504
+2,085% +$145K ﹤0.01% 5932
2023
Q3
$6.83K Sell
216
-1,260
-85% -$39.9K ﹤0.01% 7268
2023
Q2
$46.4K Buy
+1,476
New +$45.4K ﹤0.01% 6516

Other funds holding XMAR

UBS Group's XMAR Position: Q1 2026 in Review

UBS Group sold out of FT Vest US Equity Enhance & Moderate Buffer ETF March (XMAR) in Q1 2026, closing a stake of 842 shares — an estimated $33.6K sold.

UBS Group first reported a position in XMAR in Q2 2023 and held it in 10 quarters. The position peaked at $425K in Q3 2024. 69 funds tracked by Wall St. Rank hold XMAR as of Q1 2026.

  • UBS Group reported no remaining FT Vest US Equity Enhance & Moderate Buffer ETF March position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 842 FT Vest US Equity Enhance & Moderate Buffer ETF March shares in Q1 2026, an estimated $33.6K.
  • UBS Group first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF March in Q2 2023 and held it in 10 quarters.
  • UBS Group's FT Vest US Equity Enhance & Moderate Buffer ETF March position peaked at $425K in Q3 2024.
  • 69 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF March as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.